Global Regenerative Trade

FASTER FUSION.
PROVEN PERFORMANCE.

InQu® is the cell-friendly biosynthetic™ bone graft with proven clinical efficacy leading to faster bone fusion.

why us

Fast growing company

Engaged in developing

Innovative solutions

INFORMATION

about the product

CELL FRIENDLY GRAFT DELIVERS
 BETTER PATIENT OUTCOMES

Unique Formulation

InQu’s composition of a resorbable polymer, PLGA, integrated with a biologic molecule, hyaluronic acid, creates a biosynthetic scaffold ideal for bone regeneration.
________________________________________________

Tailored Resorption Time

PLGA provides a biopolymer scaffold with a resorption profile tailored to match the rate of new bone formation.
________________________________________________

Rapid Cell Binding

Hyaluronic acid creates a cell-friendly microenvironment with a favorable pH, allowing InQu to bind up to 78% of MSCs within 20 minutes. 
 
Image of InQu Products

DISCOVER A BETTER BONEGRAFT

InQu Bone Graft Extender & Substitute combines a biologic molecule with the consistency and cost effectiveness of a synthetic to create a new category of bone graft: Biosynthetic.

Proven Efficacy

Clinically proven fusion rates of 94%, outperforming fusion rates for ICBG at 12 months.

Cell-Friendly

Integrated PLGA and hyaluronic acid creates a cell-friendly microenvironment, binding MSCs and growth factors.

Success in Complex Cases

Demonstrated robust fusion, even in challenging high-risk patients.

Faster Fusion

Shorter time to fusion vs. traditional synthetic bone grafts AND superior overall fusion rates at 12 months: 93% vs. 68%

Use with Confidence

InQu offers a cost-effective, on-label solution for fusion throughout the spine.

Exceptional Handling

A cohesive, moldable putty providing ease-of-use for a variety of applications.

A Faster Path to Healing

InQu partners with the body’s natural processes to form bone in a shorter period of time without inciting an immune response. In contrast, traditional synthetics rely on inflammation and recruitment of specialized cells to digest the mineral scaffold before new bone formation can begin.

Excellent Handling In Three Configurations

InQu: Cell Friendly Bone Graft
Vivostat Logo

THE VIVOSTAT® SYSTEM

The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.

THE FULLY AUTOMATED VIVOSTAT® SYSTEM CONSISTS OF THREE COMPONENTS: